David Madden, Director at Dicerna Pharmaceuticals Inc (DRNA), bought 120,011 shares at $15.00 ($497K) on 2014-01-29, disclosed to the SEC on 2014-02-20.
Open-market purchase of $497k DRNA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.42 | 112,511 | $385K | 77.4% |
| 2 | $15.00 | 7,500 | $113K | 22.6% |
| Total | $4.14 avg | 120,011 | $497K | 100% |